EUVIMEDEUVIMED entdecken
Crossref

Akkermansia muciniphila Protects Against Trinitrobenzene Sulfonic Acid Induced Colitis by Inhibiting IL6/STAT3 Pathway

Mingshan Jiang iD, Yongbin Jia iD, Chunxiang Ma iD, Zhen Zeng iD, Yushan Wu iD, Huatian Gan, Hu Zhang iD

Inflammatory Bowel Diseases · 2025

DOI: 10.1093/ibd/izaf057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Mingshan Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Interleukin-6, Colitis. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Sichuan Province Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammatory bowel disease is a long-standing inflammatory disorder that influences the intestinal tract. The intent of this research is to explore whether the relative abundance of Akkermansia muciniphila is related to the IL6/STAT3 pathway and the fundamental molecular mechanisms of A. muciniphila on a trinitrobenzene sulfonic acid (TNBS)-induced enteritis mouse model, including the expression of inflammatory cytokines and proteins in the IL6/STAT3 signaling pathway.

Methods

The association between the A. muciniphila and IL6/STAT3 was investigated by using mucosal biopsies and fecal samples. TNBS-induced colitis mouse models were performed to elucidate the underlying mechanisms. The alteration of intestinal microbiota was organized by 16s rRNA sequencing.

Results

In Crohn’s disease patients, the level of STAT3 and IL-6 presented a negative relationship with A. muciniphila. The expression of IL-6, p-STAT3, and STAT3 was downregulated in A.m+TNBS group, indicating A. muciniphila may inhibit the IL6/STAT3 pathway in TNBS-induced enteritis in vivo. To investigate the potential defensive role of A. muciniphila supplementation in vivo with TNBS-induced enteritis, 16S rRNA sequencing was performed to analyze changes in the intestinal microbiota composition. The results revealed a marked increase in microbial diversity and abundance within the A. muciniphila-treated group, suggesting a beneficial modulation of the gut microbiome associated with the supplementation.

Conclusions

Our findings declared that A. muciniphila supplementation alleviates gastrointestinal inflammation through IL-6/STAT3 signaling pathway. This protective effect was mediated by the downregulation of the IL-6 and STAT3, highlighting a potential mechanism by which A. muciniphila modulates inflammatory responses. This work disclosed that A. muciniphila demonstrates a defensive influence against TNBS-induced enteritis in vivo, proposing it qualified as a unique therapeutic focusing on modulating IL-6, STAT3, or p-STAT3 in the treatment of colitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

STAT3 Transcription FactorInterleukin-6ColitisAnimalsTrinitrobenzenesulfonic AcidMiceHumansGastrointestinal MicrobiomeSignal TransductionDisease Models, AnimalMaleAkkermansiaFemaleCrohn DiseaseMice, Inbred C57BL

Stichwörter der Autor:innen

Akkermansia muciniphilaCrohn’s diseaseIL-6STAT3colitis

Substanzen

STAT3 Transcription FactorTrinitrobenzenesulfonic AcidInterleukin-6Stat3 protein, mouseSTAT3 protein, humanIL6 protein, human

Autor:innen und Institutionen

  • Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
  • Centre for Inflammatory Bowel Disease, West China Hospital, Sichuan University, Chengdu, China.
  • Laboratory of Inflammatory Bowel Disease, Institute of Immunology and Inflammation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Mingshan Jiang, Yongbin Jia, Chunxiang Ma, Zhen Zeng, Yushan Wu, Hu Zhang

Förderung

  • Sichuan Province Science and Technology Support Program

Zitieren

APA

Jiang, M., Jia, Y., Ma, C., Zeng, Z., Wu, Y., Gan, H., & Zhang, H. (2025). Akkermansia muciniphila Protects Against Trinitrobenzene Sulfonic Acid Induced Colitis by Inhibiting IL6/STAT3 Pathway. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izaf057

Vancouver

Jiang M, Jia Y, Ma C, Zeng Z, Wu Y, Gan H, et al. Akkermansia muciniphila Protects Against Trinitrobenzene Sulfonic Acid Induced Colitis by Inhibiting IL6/STAT3 Pathway. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izaf057

BibTeX
@article{Jiang2025,
  author = {Jiang, Mingshan and Jia, Yongbin and Ma, Chunxiang and Zeng, Zhen and Wu, Yushan and Gan, Huatian and Zhang, Hu},
  title = {Akkermansia muciniphila Protects Against Trinitrobenzene Sulfonic Acid Induced Colitis by Inhibiting IL6/STAT3 Pathway},
  journal = {Inflammatory Bowel Diseases},
  year = {2025},
  doi = {10.1093/ibd/izaf057}
}
Kostenlos starten →